AH Equity Partners Bio II, L.L.C.
SEC insider (Form 3/4/5 filer). CIK 0001725722. 10% Owner at Nautilus Biotechnology, Inc. (NAUT). 2 reported Form 4/5 transactions since Sep 2024; latest on Jun 2, 2026. Located in MENLO PARK, CA.
Companies AH Equity Partners Bio II, L.L.C. has filed insider reports for
- Nautilus Biotechnology, Inc. (NAUT): 10% Owner
AH Equity Partners Bio II, L.L.C.
CIK: 0001725722
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)2 (100.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)0 (0.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
NAUT
Nautilus Biotechnology, Inc.
10% Owner